Vesicular stomatitis virus modified with single chain IL-23 exhibits oncolytic activity against tumor cells in vitro and in vivo.
about
Vesicular stomatitis virus as a flexible platform for oncolytic virotherapy against cancerFunctional polymorphisms in interleukin-23 receptor and susceptibility to coronary artery disease.Changes in Susceptibility to Oncolytic Vesicular Stomatitis Virus during Progression of Prostate Cancer.Murine Tumor Models for Oncolytic Rhabdo-Virotherapy.Reovirus FAST Protein Enhances Vesicular Stomatitis Virus Oncolytic Virotherapy in Primary and Metastatic Tumor Models.Oncolytic Vesicular Stomatitis Virus as a Viro-Immunotherapy: Defeating Cancer with a "Hammer" and "Anvil".
P2860
Vesicular stomatitis virus modified with single chain IL-23 exhibits oncolytic activity against tumor cells in vitro and in vivo.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Vesicular stomatitis virus mod ...... or cells in vitro and in vivo.
@ast
Vesicular stomatitis virus mod ...... or cells in vitro and in vivo.
@en
type
label
Vesicular stomatitis virus mod ...... or cells in vitro and in vivo.
@ast
Vesicular stomatitis virus mod ...... or cells in vitro and in vivo.
@en
prefLabel
Vesicular stomatitis virus mod ...... or cells in vitro and in vivo.
@ast
Vesicular stomatitis virus mod ...... or cells in vitro and in vivo.
@en
P2093
P2860
P356
P1476
Vesicular stomatitis virus mod ...... mor cells in vitro and in vivo
@en
P2093
Carol Shoshkes Reiss
James M Miller
Sarah McNulty Bidula
P2860
P356
10.2147/IJICMR.S9528
P577
2010-05-01T00:00:00Z